<DOC>
	<DOCNO>NCT02974075</DOCNO>
	<brief_summary>Despite continuous technical improvement urologic surgery , 40 % prostate cancer patient develop biochemical recurrence radical prostatectomy ( RP ) , potentially micro metastasis time primary surgery . With improved radiological modality nuclear medicine tracer like 68Ga-PSMA PET/CT , allow localization site recurrence , increase interest metastasis direct therapy , salvage lymph node dissection . The pelvic extend salvage lymph node dissection ( sLND ) promising option treat prostate cancer patient local recurrence radical prostatectomy curative intent . Several retrospective series publish determine local value sLND . Despite first data seem feasible promising , date prospective evaluation make . Thus sLND still experimental accord guideline consider label therapy . This prospective single center phase I/II study conduct investigate safety early efficacy salvage lymph node dissection prostate cancer patient local pelvic recurrence radical prostatectomy ( RP ) curative intention .</brief_summary>
	<brief_title>Salvage Lymph Node Dissection Prostate Cancer Patients With Recurrence After Radical Prostatectomy</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Recurrence</mesh_term>
	<criteria>Prostate cancer patient lymph node metastasis pelvic image Status post radical prostatectomy curative intent Ability inform consent No sign bone visceral metastasis Male &gt; 18 year ECOG performance status 0 1 Male &lt; 18 year No ability inform consent Sign bone visceral metastasis Deep venous thrombosis pulmonary embolism within last 6 month study screen ECOG performance status 2</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>